Everything A Gay Man Needs
Connect
  • Home
  • About the Author
  • Workshops
  • Health Risk & HIV
  • Articles
    • HIM Articles
    • Huffington Post Articles
    • Hot Topics
    • Other Articles Written by Dick Keiser Jr PhD
  • Contact
  • Untitled

Here’s Why Gilead Sciences, Inc (GILD) Stock May Continue To Slide

12/24/2014

0 Comments

 
Gilead recorded its largest ever one-day decline yesterday after Express Scripts dropped the company’s hepatitis C drugs for a competitor’s treatment. Gilead may be in for some more bad news soon if Achillion releases positive trial results for its experimental hepatitis C combo, ACH-3102

GILD ACHN ABBV ESRX http://www.bidnessetc.com/31504-gilead-sciences-gild-may-have-to-cut-price-of-hepatitis-c-drug-to-battle-co/

By: HANNAH ISHMAEL
Published: Dec 23, 2014 at 5:46 am EST 
Read more ....



0 Comments



Leave a Reply.

    Articles

    I consider pertinent regarding Gay health and HIV

    Categories

    All

    RSS Feed